J&J Harnessing Pharma Business Advantages For Global OTC Growth
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's consumer products division is leveraging the capabilities of its prescription pharmaceutical business infrastructures to grow its "iconic brands" and create new products
You may also be interested in...
J&J Sees Opportunities In Wellness Under Health Care Reform
Johnson & Johnson sees multiple business opportunities in the Obama administration's emphasis on wellness and prevention as part of its health care reform agenda
J&J Sees Opportunities In Wellness Under Health Care Reform
Johnson & Johnson sees multiple business opportunities in the Obama administration's emphasis on wellness and prevention as part of its health care reform agenda
J&J Sees Opportunities In Wellness Under Health Care Reform
Johnson & Johnson sees multiple business opportunities in the Obama administration's emphasis on wellness and prevention as part of its health care reform agenda